SELF-TEST FOR SARS-COV-2 ANTIGEN (CORONAVIRUS) - ANVISA Registration 80560310085

Access comprehensive regulatory information for SELF-TEST FOR SARS-COV-2 ANTIGEN (CORONAVIRUS) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80560310085 and manufactured by manufacturer not specified. The registration is held by MEDLEVENSOHN COMÉRCIO E REPRESENTAÇÕES DE PRODUTOS HOSPITALARES LTDA with validity until Jul 18, 2032.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including HANGZHOU ALLTEST BIOTECH CO. LTD, GENRUI BIOTECH INC., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80560310085
2 Related Devices
Registration Details
ANVISA Registration Number: 80560310085
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

Flowflex - Teste Rápido de Detecção de Antígeno do COVID-19 - Autoteste
Risk Class III

Registration Details

80560310085

25351078944202257

05343029000190

Dates and Status

Jul 18, 2022

18/07/2032

09/18/2025 19:00:01

Flowflex - Teste Rápido de Detecção de Antígeno do COVID-19 - Autoteste
Risk Class III

Registration Details

80560310085

25351078944202257

05343029000190

Company Information

China
PT: CHINA, REPÚBLICA POPULAR

Dates and Status

Jul 18, 2022

18/07/2032

09/18/2025 19:00:01